Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Dermatology

Building Your LV Care Team

At a Glance

Because Livedoid Vasculopathy is a complex clotting disorder, successful treatment requires a multidisciplinary medical team. Most patients need a vascular dermatologist for skin ulcers, a hematologist for underlying blood issues, and a rheumatologist to check for autoimmune triggers.

Because Livedoid Vasculopathy (LV) is a rare and complex condition, it often cannot be managed by a single doctor. Successful treatment frequently requires a multidisciplinary care team—a group of specialists from different fields working together to address the skin symptoms, the underlying blood chemistry, and the pain [1][2]. Building this team is an essential step in moving from a diagnosis to a long-term management plan.

The Essential Specialists

While your team may grow over time, most patients with LV benefit from working with three primary types of specialists:

1. The Dermatologist (Your “General”)

The dermatologist is usually the first to identify LV. You should look for a specialist in Vascular Dermatology or Complex Medical Dermatology [3][4]. Their role is to:

  • Perform and interpret your skin biopsies [5].
  • Differentiate LV from “look-alike” conditions like vasculitis or pyoderma gangrenosum [6][4].
  • Manage wound care for active ulcers [7].

2. The Hematologist (The Blood Specialist)

Since LV is a thrombo-occlusive (clotting) disorder, a hematologist is vital for looking “under the hood” [1][8]. Look for a hematologist who specializes in thrombosis and hemostasis (clotting and bleeding disorders). They will:

  • Perform a deep “thrombophilia workup” to check for genetic or acquired clotting risks [1][9].
  • Help manage and monitor long-term anticoagulant (blood thinner) therapy [10][11].

3. The Rheumatologist (The Immune Specialist)

LV sometimes occurs alongside autoimmune conditions like Systemic Lupus Erythematosus (SLE) [12][13]. A rheumatologist will:

  • Screen for markers of connective tissue disease [1][12].
  • Help manage medications if an autoimmune trigger is found [8].

Vetting Your Specialists

Because LV is rare, not all doctors will have treated it before. You are entitled to ask questions to ensure your team has the right expertise. Consider asking:

  • “How many patients with Livedoid Vasculopathy have you treated?”
  • “Do you believe this is a clotting problem or an inflammatory problem? Why?” (A doctor who insists it is “just inflammation” may not be current on the latest LV research [6][8]).
  • “Are you comfortable coordinating my treatment with specialists in other departments?” [1].

What to Bring to Your First Visit

To get the most out of a consultation, especially at a large university hospital, bring the following “artifacts”:

  • Pathology Slide Transfers: Don’t just bring the paper report. Call the facility where your biopsy was done and request that your original pathology slides be formally transferred or mailed to your new specialist’s pathology department for a “re-read.” (Note: Most hospitals will not hand original glass slides directly to patients due to strict medical-legal chain-of-custody rules) [14].
  • The “Photo Timeline”: High-resolution photos of your lesions in different stages (the purple lace-like pattern, active open ulcers, and the white scars) [7][15].
  • Complete Lab History: A folder containing all blood work from the last 1–2 years, especially any clotting or autoimmune panels [1][16].
  • Medication List: A clear list of what you’ve tried (e.g., Prednisone, Aspirin, creams) and, most importantly, whether it helped or made things worse [8].

A multidisciplinary approach ensures that you aren’t just treating the skin on the surface, but addressing the systemic factors that cause the clots in the first place [11][1].

Common questions in this guide

What kind of doctors treat Livedoid Vasculopathy?
Treatment for Livedoid Vasculopathy typically requires a multidisciplinary team. This usually includes a complex medical dermatologist, a hematologist to manage underlying clotting issues, and sometimes a rheumatologist if an autoimmune condition is present.
Why do I need to see a hematologist for a skin condition like LV?
Because Livedoid Vasculopathy is a thrombo-occlusive or clotting disorder, the skin ulcers are caused by underlying blood flow issues. A hematologist specializes in identifying genetic clotting risks and managing long-term blood thinner therapy to prevent new ulcers from forming.
How should I prepare for my first appointment with a new LV specialist?
You should arrange to have your original pathology slides transferred to the new doctor for a re-read. It is also helpful to bring a high-resolution photo timeline of your skin lesions, a complete lab history from the past two years, and a detailed medication list showing what has or hasn't worked.
How does a doctor tell the difference between Livedoid Vasculopathy and vasculitis?
A specialist, usually a vascular dermatologist, will perform and interpret skin biopsies to distinguish LV from inflammatory conditions like vasculitis. While vasculitis is driven by inflammation, LV is primarily driven by blood clots.
What should I look for when choosing a dermatologist for LV?
Look for a specialist in Vascular Dermatology or Complex Medical Dermatology. It is important to ask how many LV patients they have treated and if they are comfortable coordinating your care with hematologists and rheumatologists.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do you have experience treating Livedoid Vasculopathy specifically, and how many cases have you managed in the past year?
  2. 2.How do you distinguish between LV and inflammatory vasculitis when choosing a treatment plan?
  3. 3.Will you be coordinating my care with a hematologist to screen for underlying clotting disorders (thrombophilia)?
  4. 4.If we suspect an autoimmune trigger, will a rheumatologist be consulted to help manage those symptoms?
  5. 5.Who is the best point of contact on your team if I have a sudden, painful flare-up between appointments?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Livedoid vasculopathy in 75 Brazilian patients in a single-center institution: Clinical, histopathological and therapy evaluation.

    Criado PR, Pagliari C, Morita TCAB, et al.

    Dermatologic therapy 2021; (34(2)):e14810 doi:10.1111/dth.14810.

    PMID: 33496999
  2. 2

    Livedoid vasculopathy - A diagnostic and therapeutic challenge.

    Burg MR, Mitschang C, Goerge T, Schneider SW

    Frontiers in medicine 2022; (9()):1012178 doi:10.3389/fmed.2022.1012178.

    PMID: 36262273
  3. 3

    Chronic ulcer in a patient with essential thrombocythemia taking hydroxyurea.

    Maloney N, Novoa R, Yeh JE

    Dermatology online journal 2024; (30(3)) doi:10.5070/D330363872.

    PMID: 39090045
  4. 4

    Occlusive cutaneous vasculopathies as cause of chronic ulcers.

    Ronicke M, Berking C, Erfurt-Berge C

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2024; (22(4)):553-567 doi:10.1111/ddg.15276.

    PMID: 38379266
  5. 5

    Livedoid vasculopathy: how to diagnose and how to treat?

    Lipsker D

    Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(9)):1627-1628 doi:10.1111/jdv.15830.

    PMID: 31468610
  6. 6

    Inflammatory and vaso-occlusive ulcers: Part I - Clinical presentation and diagnosis.

    Shakshouk H, Hines A, Kody S, et al.

    Journal of the American Academy of Dermatology 2024; (91(6)):1035-1048 doi:10.1016/j.jaad.2024.01.083.

    PMID: 38432459
  7. 7

    Characteristics, risk factors and treatment reality in livedoid vasculopathy - a multicentre analysis.

    Weishaupt C, Strölin A, Kahle B, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(9)):1784-1791 doi:10.1111/jdv.15639.

    PMID: 31009111
  8. 8

    Retiform non-blanchable purpuric plaques in a patient with systemic lupus erythematosus.

    Grinnell M, Bath A, DiMaio D, et al.

    Lupus 2019; (28(8)):1013-1016 doi:10.1177/0961203319847274.

    PMID: 31126212
  9. 9

    Livedoid vasculopathy: does hyperhomocysteinaemia play an aetiological role?

    Marsch WC, Komatsuzaki S, Mueller A, et al.

    European journal of dermatology : EJD 2019; (29(3)):287-293 doi:10.1684/ejd.2019.3554.

    PMID: 31389788
  10. 10

    Long-Term Efficacy of Guideline-Followed Treatment in Patients with Livedoid Vasculopathy: A Single-Center Study.

    Hillgruber C, Mitschang C, Eveslage M, et al.

    Advances in wound care 2025; doi:10.1177/21621918251395013.

    PMID: 41264385
  11. 11

    Addressing Diagnostic Challenges in Livedoid Vasculopathy: A Case Report on Interdisciplinary Management.

    Ríos Padín J, Rivera Rodríguez DM, Nuñez Morales J, Álvarez Cardín N

    Cureus 2024; (16(10)):e72554 doi:10.7759/cureus.72554.

    PMID: 39606545
  12. 12

    Prevalence of Livedoid Vasculopathy Among Patients with Connective Tissue Diseases and Its Association with Thrombophilic Factors: A Hospital-Based Retrospective Cohort (2014-2021).

    Argobi Y

    Clinical, cosmetic and investigational dermatology 2025; (18()):2971-2977 doi:10.2147/CCID.S551007.

    PMID: 41234949
  13. 13

    Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin.

    Yoshioka K, Tateishi C, Kato H, Chen KR

    Clinical case reports 2018; (6(11)):2045-2047 doi:10.1002/ccr3.1803.

    PMID: 30455888
  14. 14

    Direct immunofluorescence findings in livedoid vasculopathy: a 10-year study and literature review.

    Nuttawong S, Chularojanamontri L, Trakanwittayarak S, et al.

    Clinical and experimental dermatology 2021; (46(3)):525-531 doi:10.1111/ced.14464.

    PMID: 32986882
  15. 15

    Identification of Challenging Diagnostic Factors in Livedoid Vasculopathy: A Retrospective Study.

    Qi F, Gao Y, Jin H

    Clinical, cosmetic and investigational dermatology 2024; (17()):1747-1756 doi:10.2147/CCID.S466449.

    PMID: 39109220
  16. 16

    Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease.

    Reagin H, Marks E, Weis S, Susa J

    The American Journal of dermatopathology 2018; (40(9)):682-685 doi:10.1097/DAD.0000000000001133.

    PMID: 29533274

This page is for informational purposes only and is intended to help you coordinate your Livedoid Vasculopathy care. Always consult your healthcare providers for specific medical advice and treatment planning.

Get notified when new evidence is published on Livedoid vasculopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.